Dystrophic Epidermolysis Bullosa
📧 Sign up to get email alerts when something new happens for Dystrophic Epidermolysis Bullosa.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-06-30EMA Authorised: Vyjuvek (Beremagene geperpavec) — Krystal Biotech Netherlands B.V.
The European Medicines Agency has authorised Vyjuvek (beremagene geperpavec) for dystrophic epidermolysis bullosa in the EU, with orphan med…
-
EMA approval · 2025-02-28First topical gene therapy treatment for dystrophic epidermolysis bullosa
The European Medicines Agency approved Vyjuvek as the first topical gene therapy for dystrophic epidermolysis bullosa, an ultra-rare genetic…